BackImmunome Overview

Immunome Gross Profit

Gross Profit analysis for IMNM.

Quarterly Gross Profit

$-753000.00
↓ 125.73% YoY

As of Mar 31, 2026

Annual Gross Profit (TTM)

$2.49M
↓ 75.78% YoY

Trailing 12 months ending Mar 31, 2026

Average Gross Profit (Comparison Companies)

Gross Profit History

Gross Profit Comparison

Annual Gross Profit Growth Rate (%)

Annual Gross Profit Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin